Efficacy of the butterfly positioning Maneeveda in reducing 1 st stage of labor duration in nulliparous pregnancy woman give birth at Sunpasittiprasong hospital parallel group controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200712003

Enrollment

102

Registered

2020-07-12

Start date

2020-06-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

positoning during labor pain 1st stage of labor Maneevada

Interventions

Supportive during 1st stage of labor,Positioning during 1st stage of labor

Placebo Comparator No treatment,Experimental Other

Control,Butterfly position

Eligibility

Sex/Gender

Female

Age

15 Years to 34 Years

Inclusion criteria

Inclusion criteria: Nulliparus singleton pregnancy Gestational age 37-41 weeks Cervical dilatation 3-6 cm Cephalic presentation

Exclusion criteria

Exclusion criteria: Maternal: hypertensive disorder, GDM, hearing difficulties, PROM, short stature (<150cm), placenta previa Fetal: IUGR, macrosomia, fetal anomaly, DFIU, preterm, multiple pregnancy

Design outcomes

Primary

Measure	Time frame
1st stage of labor time time at cervical fully dilatation Butterful position during 1st stage of labor	—

Secondary

Measure	Time frame
pain during first stage of labor pain score,2nd stage of labor time during 2nd stage of labor time child delivery to placental delivery,reduce drug used for augmentation and induction of labor during first stage of labor Drug use rate,redure obstetrics procedure during 2nd stage of labor route of delivery,Maternal complication (postpartum hemorrhage) during 2nd stage of labor estimated blood loss,Neonatal complication during 2nd stage of labor APGAR score ,rate of initial step and admit NICU	—

Measure

Time frame

pain during first stage of labor pain score,2nd stage of labor time during 2nd stage of labor time child delivery to placental delivery,reduce drug used for augmentation and induction of labor during first stage of labor Drug use rate,redure obstetrics procedure during 2nd stage of labor route of delivery,Maternal complication (postpartum hemorrhage) during 2nd stage of labor estimated blood loss,Neonatal complication during 2nd stage of labor APGAR score ,rate of initial step and admit NICU

—

Countries

Thailand

Contacts

Public ContactWasuthep Sae-Tia

Sappasitthiprasong Hospital

wasuthep.md@gmail.com094-9298652

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026